← Evidence map

ArticleCell insight2025

Development of a comparative high-throughput screening platform for identifying glioblastoma subtype specific inhibitors.

Zilai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41321709